BioMed Realty Trust (BioMed Realty Trust) Float Percentage Of Total Shares Outstanding : 85.96% (As of Apr. 29, 2024)

View and export this data going back to . Start your Free Trial

What is BioMed Realty Trust Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BioMed Realty Trust's float shares is 174.95 Mil. BioMed Realty Trust's total shares outstanding is 203.53 Mil. BioMed Realty Trust's float percentage of total shares outstanding is 85.96%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BioMed Realty Trust's Insider Ownership is 0.64%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BioMed Realty Trust's Institutional Ownership is 99.04%.

BioMed Realty Trust Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

BioMed Realty Trust's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	174.95	/	203.53
	=	85.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioMed Realty Trust (BioMed Realty Trust) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » BioMed Realty Trust Inc (NYSE:BMR) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.biomedrealty.com

BioMed Realty Trust Inc, a Maryland corporation was formed on April 30, 2004 and commenced operations on August 11, 2004, after completing its initial public offering. The Company operates as a self-administered and self-managed real estate investment trust focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry mainly through its subsidiary, BioMed Realty, L.P., a Maryland limited partnership Its tenants mainly include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are generally located in markets with well established reputations as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/ New Jersey. The Company faces competition from various entities for investment opportunities in properties for life science tenants, including other REITs, such as health care REITs and suburban office property REITs, pension funds, insurance companies, investment funds and companies, partnerships, and developers. The Company's properties are subject to various laws, ordinances and regulations, including regulations relating to common areas.

Executives

Daniel Bradbury	director	BIOBRIT, LLC, 2223 AVENIDA DE LA PLAYA, SUITE 108, LA JOLLA CA 92037
Brody William R Md Phd	director	MEDTRONIC, INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604
Janice L. Sears	director	1100 PARK PLACE, SUITE 200, SAN MATEO CA 94403
Alan D Gold	director, officer: Chairman, President and CEO	17140 BERNARDO CENTER DRIVE, SUITE 195, SAN DIEGO CA 92128
Gary A Kreitzer	director, officer: Exec VP and Assistant Sec	17140 BERNARDO CENTER DRIVE, SUITE 195, SAN DIEGO CA 92128
Margaret Faye Wilson	director	12836 LUNADA PLACE, SAN DIEGO CA 92128
Griffin R Kent Jr	officer: President and COO	5950 SHERRY LANE, SUITE 700, DALLAS TX 75225
Richard I Gilchrist	director	5950 SHERRY LANE, SUITE 700, DALLAS TX 75225